Cationic compounds used in lipoplexes and polyplexes for gene delivery

Area of Science:

• Biochemistry
• Molecular Biology
• Materials Science

Background:

• Gene transfer is a key therapeutic strategy for genetic and acquired diseases.
• Cationic lipids and polymers are non-viral vectors for gene delivery, offering advantages like reduced immunogenicity and oncogenicity compared to viral methods.
• Existing cationic compounds often suffer from poor transfection efficiency and cellular toxicity.

Purpose of the Study:

• To review cationic lipids for gene therapy from a chemical perspective.
• To classify various types of cationic compounds used in gene therapy.
• To provide insights for the future development of novel cationic gene delivery systems.

Main Methods:

• Literature review of cationic compounds used in gene therapy.
• Classification of cationic compounds based on their chemical structure.
• Discussion of chemical properties influencing transfection efficiency and toxicity.

Main Results:

• Identified and categorized cationic compounds into monovalent cationic lipids, polyvalent cationic lipids, cationic polymers, guanidine-containing compounds, cationic peptides, and cholesterol-containing compounds.
• Highlighted the chemical basis for the advantages and limitations of current gene transfer agents.
• Emphasized the ongoing development of new cationic compounds to overcome existing challenges.

Conclusions:

• Cationic compounds represent a promising alternative to viral vectors for gene therapy.
• Understanding the chemistry of these compounds is crucial for optimizing their performance.
• Further research into novel cationic lipid and polymer design is essential for advancing gene therapy applications.